SKELTON LAURENCE MATTHEW enters VERA THERAPEUTICS, INC. with 45.80K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/30/2026ACC: 0001193125-26-031763
Officer· Chief Commercial Officer
Since Feb 2026
45.80K
Baseline shares
100% direct
45.80K
Direct ownership
2 positions
91.50K
Derivative underlying
2 instruments
2
Security positions
All direct
Non-Derivative Holdings2
Class A Common Stock
DirectShares owned30K
Class A Common Stock
DirectShares owned15.80K
Total
45.80K direct45.80K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 30K | Direct |
| Class A Common Stock | 15.80K | Direct |
| Total | 45.80K | 45.80K direct |
Derivative Holdings2
Stock Option (right to buy)
DirectUnderlying security
Class A Common Stock
Underlying shares
31.50K
Shares owned
N/A
Exercise price
29.18
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Class A Common Stock
Underlying shares
60K
Shares owned
N/A
Exercise price
41.75
Expiration
—
Exercise window
—
Total
Underlying
91.50K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Class A Common Stock | 29.18 | — | — | 31.50K | N/A |
| Stock Option (right to buy) Direct | Class A Common Stock | 41.75 | — | — | 60K | N/A |
| Total | 91.50K | 0.00 | ||||